Alzheimer Disease, drug therapy

Alzheimer Disease, drug therapy
Accession Number

Not Available

DrugDrug Description
CrenezumabCrenezumab has been used in trials studying the treatment of Alzheimer's Disease.
TricaprylinTricaprilin has been used in trials studying the supportive care and treatment of Alzheimer's Disease.
DonanemabDonanemab (LY3002813) is a humanized IgG1 monoclonal antibody targeted against an epitope at the N-terminal of a specific type of amyloid beta (Aβ) - pyroglutamate Aβ - which is found...
AducanumabA monoclonal antibody indicated in the treatment of Alzheimer's disease.
LecanemabAn amyloid beta-targeting antibody used to treat Alzheimer’s Disease in patients with mild cognitive impairment or mild dementia with a known amyloid beta pathology.
Drugs & Drug Targets
AducanumabAmyloid beta A4 proteintarget
LecanemabAmyloid beta A4 proteintarget